LLY

970.87

+2.45%↑

JNJ

221.5

+0.17%↑

ABBV

203.32

+1.08%↑

UNH

381.9

+0.65%↑

AZN

182.77

+0.25%↑

LLY

970.87

+2.45%↑

JNJ

221.5

+0.17%↑

ABBV

203.32

+1.08%↑

UNH

381.9

+0.65%↑

AZN

182.77

+0.25%↑

LLY

970.87

+2.45%↑

JNJ

221.5

+0.17%↑

ABBV

203.32

+1.08%↑

UNH

381.9

+0.65%↑

AZN

182.77

+0.25%↑

LLY

970.87

+2.45%↑

JNJ

221.5

+0.17%↑

ABBV

203.32

+1.08%↑

UNH

381.9

+0.65%↑

AZN

182.77

+0.25%↑

LLY

970.87

+2.45%↑

JNJ

221.5

+0.17%↑

ABBV

203.32

+1.08%↑

UNH

381.9

+0.65%↑

AZN

182.77

+0.25%↑

Начало・Списък с акции・ResMed Inc

ResMed Inc

Отворен

СекторЗдравеопазване

200.1 -3.14

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

199.2

Максимум

206.59

Ключови измерители
By Trading Economics
Приходи	6.1M 399M
Продажби	8.6M 1.4B
P/E Средно за сектора	19.758 49.8
EPS	2.86
Дивидентна доходност	1.14
Марж на печалбата	27.856
Служители	10,600
EBITDA	-67M 500M

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+27.96% upside

Дивиденти
By Dow Jones
Дивидентна доходност Средно за сектора	1.14% 2.25%
Следващи печалби	30.07.2026 г.
Следваща дата на дивидент	18.06.2026 г.
Следваща дата на екс-дивидент	14.05.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-2B 30B
Предишно отваряне	203.24
Предишно затваряне	200.1

Настроения в новините

By Acuity

82%

18%

326 / 347 Класиране в Healthcare

ResMed Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

10.05.2026 г., 23:47 ч. UTC

Пазарно говорене

Gold Falls on Renewed Inflation Concerns -- Market Talk

10.05.2026 г., 23:44 ч. UTC

Пазарно говорене

Nikkei May Rise on Signs of U.S. Economic Strength -- Market Talk

10.05.2026 г., 23:38 ч. UTC

Пазарно говорене

Oil Rises Amid Signs of Ongoing Middle East Tensions -- Market Talk

10.05.2026 г., 23:14 ч. UTC

Пазарно говорене

Australia's Political Map Continues to Be Redrawn -- Market Talk

10.05.2026 г., 22:22 ч. UTC

Придобивния, сливания и поглъщания

Elevra Lithium: Expects Deal to Close in 1Q FY27

10.05.2026 г., 22:21 ч. UTC

Придобивния, сливания и поглъщания

Elevra Lithium: Expects to Received About $71 Million Before Fees, Taxes in Cash

10.05.2026 г., 22:21 ч. UTC

Придобивния, сливания и поглъщания

Elevra Lithium Agrees to Sell Ewoyaa Lithium Project Stake to Zhejiang Huayou Cobalt

10.05.2026 г., 10:21 ч. UTC

Печалби

Saudi Aramco Profit Jumps Despite War Disrupting Shipping Routes -- WSJ

9.05.2026 г., 06:05 ч. UTC

Печалби

Our Innodata Stock Pick Smashed Earnings Expectations. Stay Long. -- Barrons.com

8.05.2026 г., 23:55 ч. UTC

Печалби

Review & Preview: Still Going Strong -- Barrons.com

8.05.2026 г., 20:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

8.05.2026 г., 20:49 ч. UTC

Печалби

Why the Gap Between Chip and Software Stocks Keeps Getting Wider -- Barrons.com

8.05.2026 г., 20:25 ч. UTC

Печалби

These Stocks Are Today's Movers: Rocket Lab, Moderna, HubSpot, Nvidia, CoreWeave, Trade Desk, Cloudflare, Fluor, Akamai, IREN, and More -- Barrons.com

8.05.2026 г., 19:43 ч. UTC

Печалби

Cencosud 1Q Rev $4.565B >CENCOSUD.SN

8.05.2026 г., 19:43 ч. UTC

Печалби

Cencosud 1Q Net $115M

8.05.2026 г., 19:20 ч. UTC

Пазарно говорене

Oil Futures End Session Higher, But Down on the Week -- Market Talk

8.05.2026 г., 19:18 ч. UTC

Печалби

Monster and Celsius Earnings Show Energy-Drink Fatigue Is Far From Over -- Barrons.com

8.05.2026 г., 19:16 ч. UTC

Печалби

This Mini Berkshire Hathaway Is a Buy. An Activist Investor Is Pushing to Break It Up. -- Barrons.com

8.05.2026 г., 19:08 ч. UTC

Печалби

This Mini Berkshire Hathaway Is a Buy. An Activist Investor Is Pushing to Break It Up. -- Barrons.com

8.05.2026 г., 19:05 ч. UTC

Печалби

Investors Feared Energy-Drink Fatigue. Monster and Celsius Earnings Offered Reassurance. -- Barrons.com

8.05.2026 г., 19:02 ч. UTC

Пазарно говорене

U.S. Natural Gas Futures Little Changed on Week -- Market Talk

8.05.2026 г., 18:51 ч. UTC

Печалби

Memory Stocks Continue to Surge. What's Driving Micron and Sandisk Higher. -- Barrons.com

8.05.2026 г., 18:49 ч. UTC

Печалби

These Stocks Are Today's Movers: Rocket Lab, Moderna, HubSpot, Nvidia, CoreWeave, Trade Desk, Cloudflare, Fluor, Akamai, IREN, and More -- Barrons.com

8.05.2026 г., 18:41 ч. UTC

Печалби

McDonald's Stock Rises on Earnings Beat. The Value Push Needs to Maintain Momentum. -- Barrons.com

8.05.2026 г., 17:38 ч. UTC

Пазарно говорене

U.S. Oil Rig Count Rises By 2 to 410 -- Market Talk

8.05.2026 г., 17:14 ч. UTC

Печалби

How High Gas Prices Need to Rise to Boost Electric Vehicle Sales -- Barrons.com

8.05.2026 г., 17:04 ч. UTC

Пазарно говорене

Zcash Caps Off Parabolic Week -- Market Talk

8.05.2026 г., 16:20 ч. UTC

Пазарно говорене

Tech, Media & Telecom Roundup: Market Talk

8.05.2026 г., 16:20 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

8.05.2026 г., 16:15 ч. UTC

Пазарно говорене

Global Commodities Roundup: Market Talk

Сравнение с други в отрасъла

Ценова промяна

ResMed Inc Прогноза

Ценова цел

By TipRanks

27.96% нагоре

12-месечна прогноза

Среден 264.56 USD 27.96%

Висок 340 USD

Нисък 225 USD

Според 13 анализатори от Wall Street, предложили 12-месечна ценова цел за ResMed Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

13 ratings

Купи

Задържане

Продай

Според 13 анализатори, дали борсови рейтинги на ResMed Inc през последните 3 месеца.

Настроение

By Acuity

326 / 347 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.